Mahana Therapeutics

Germany-headquartered Bayer (ETR: BAYN) has announced a strategic partnership with US digital developer Mahana Therapeutics. The collaboration focuses on the distribution and marketing of Mahana’s digital technologies, further expanding Bayer’s foray into the digital health sector. This move follows Bayer’s launch earlier this year of a precision health product development…